Pursuant to Regulation 30 & 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that the Company will host Investor Conference Call on Wednesday, May 21, 2025 at 06:00 PM (IST) for Q4 & FY25. Details of the Investor Conference Call are enclosed. The same are also being uploaded on website of the Company at www.mankindpharma.com.
The above information is a part of company’s filings submitted to BSE.